Michele Pavarana

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer

Annamaria Molino, Monica Giovannini, A. Auriemma et al. · Critical Reviews in Oncology/Hematology · 2006 · 68 citations

Medicine, Oncology, Surgery +17

Neoadjuvant therapy with weekly docetaxel and cisplatin, 5‐fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long‐lasting pathological complete response

Felice Pasini, Giovanni De Manzoni, Andrea Zanoni et al. · Cancer · 2012 · 51 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne

Francesco Casella, Maria Bencivenga, Riccardo Rosati et al. · Pleura and Peritoneum · 2022 · 43 citations · Full text

Medicine, Oncology, Surgery +17

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial

Valeria Merz, Camilla Zecchetto, Francesca Simionato et al. · Therapeutic Advances in Medical Oncology · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17